HCPCS J-code
J0179: brolucizumab
Brolucizumab 1 mg (anti-VEGF, AMD)
Code
J0179
Generic
brolucizumab
Brands
Beovu
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- Step therapy anti-VEGF
- Safety profile concerns
Frequently asked questions
What is HCPCS J0179?
Brolucizumab 1 mg (anti-VEGF, AMD)
Why does insurance commonly deny J0179?
Step therapy anti-VEGF; Safety profile concerns.
What brand-name drug uses J0179?
Beovu.
Related
Appeal a J0179 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com